New study examines link between brain cortex and food buying habits
MONTREAL: Will that be a pizza for you or will you go for a salad? Choosing what you eat is not simply a matter of taste, conclude scientists in a new study at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre. As you glance over a menu or peruse the shelves in a supermarket, your brain is making decisions based more on a food’s caloric content.
Amyotrophic lateral sclerosis (ALS), also known as “Lou Gehrig’s Disease,” is a devastating fatal disease of the nervous system that kills two to five Canadians every day. On September 19th and 20th, the Montreal Neurological Institute and Hospital (The Neuro), at McGill University and the McGill University Health Centre will host the 10th Annual ALS Symposium of the Fondation André-Delambre. Nearly one hundred researchers and clinicians from several countries will come together to discuss recent progress in ALS research.
Dr. Peter McPherson,James McGill Professor of Neurology and Neurosurgery, and Anatomy and Cell Biology at the Montreal Neurological Institute, McGill University has been named a Fellow of the Royal Society of Canada (RSC).
Dr. Alan Evans, a pioneering scientist who has helped map the human brain, has been awarded the Margolese National Brain Disorders Prize by the University of British Columbia. Dr. Evans is a researcher at the Montreal Neurological Institute and the James McGill Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering at McGill University.
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes. Identifying SUMO’s role in the cancer cell growth will lead to a new strategy for glioblastoma treatment.